We are live on ! Find out more
GC

Guggenheim Capital Portfolio holdings

AUM $12.9B
1-Year Est. Return 27.3%
This Fund
S&P 500
This Quarter Est. Return
+8.95%
1 Year Est. Return
+27.3%
3 Year Est. Return
+83.37%
5 Year Est. Return
+104.66%
10 Year Est. Return
+386.48%
AUM
$13.8B
AUM Growth
+$1.18B
Cap. Flow
+$317M
Cap. Flow %
2.3%
Top 10 Hldgs %
23.89%
Holding
1,675
New
92
Increased
753
Reduced
716
Closed
103

Top Sells

Rank Stock Value
1
NVDA icon
NVIDIA
NVDA
+$16.8M
2
IBM icon
IBM
IBM
+$10.2M
3
ANSS
Ansys
ANSS
+$8.94M
4
QCOM icon
Qualcomm
QCOM
+$7.56M
5
TSLA icon
Tesla
TSLA
+$6.76M

Sector Composition

Rank Sector Weight
1 Technology 29.82%
2 Consumer Discretionary 8.62%
3 Communication Services 8.47%
4 Healthcare 7.28%
5 Financials 6.73%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
DBX icon
1076
Dropbox
DBX
$8.12B
$655K ﹤0.01%
21,667
+6,465
+43% +$185K
ENIC icon
1077
Enel Chile
ENIC
$6.28B
$652K ﹤0.01%
167,678
-58,875
-26% -$206K
CHKP icon
1078
Check Point Software Technologies
CHKP
$13.1B
$649K ﹤0.01%
3,136
+837
+36% +$169K
DTM icon
1079
DT Midstream
DTM
$13.4B
$649K ﹤0.01%
5,738
+17
+0.3% +$1.78K
NHI icon
1080
National Health Investors
NHI
$3.65B
$645K ﹤0.01%
8,110
-5,469
-40% -$409K
DLX icon
1081
Deluxe
DLX
$1.15B
$644K ﹤0.01%
33,248
-873
-3% -$15.9K
GDO
1082
Western Asset Global Corporate Defined Opportunity Fund
GDO
$77.4M
$642K ﹤0.01%
54,081
-17,188
-24% -$204K
BNS icon
1083
Scotiabank
BNS
$108B
$642K ﹤0.01%
9,929
-5,448
-35% -$321K
PHI icon
1084
PLDT
PHI
$4.33B
$642K ﹤0.01%
34,305
+15,617
+84% +$335K
SLNO
1085
DELISTED
Soleno Therapeutics
SLNO
$640K ﹤0.01%
+9,468
New +$702K
AGIO icon
1086
Agios Pharmaceuticals
AGIO
$1.93B
$638K ﹤0.01%
15,902
-2,002
-11% -$75.3K
IMVT icon
1087
Immunovant
IMVT
$8.25B
$636K ﹤0.01%
39,445
-2,056
-5% -$33.3K
KTF
1088
DWS Municipal Income Trust
KTF
$352M
$635K ﹤0.01%
69,258
+17,254
+33% +$152K
EXP icon
1089
Eagle Materials
EXP
$6.57B
$631K ﹤0.01%
2,709
-86
-3% -$19.5K
CNA icon
1090
CNA Financial
CNA
$14.1B
$628K ﹤0.01%
13,510
-540
-4% -$25K
NXT icon
1091
Nextpower Inc
NXT
$15.7B
$626K ﹤0.01%
8,466
+2,160
+34% +$139K
GTM
1092
ZoomInfo Technologies
GTM
$1.22B
$624K ﹤0.01%
57,181
+2,120
+4% +$22.7K
H icon
1093
Hyatt Hotels
H
$16.7B
$623K ﹤0.01%
4,388
-247
-5% -$35.4K
TXRH icon
1094
Texas Roadhouse
TXRH
$13.7B
$620K ﹤0.01%
3,734
-100
-3% -$17.6K
RMT
1095
Royce Micro-Cap Trust
RMT
$761M
$620K ﹤0.01%
59,673
-23,296
-28% -$230K
RH icon
1096
RH
RH
$3.71B
$618K ﹤0.01%
3,044
-82
-3% -$17.8K
TRIN icon
1097
Trinity Capital Inc.
TRIN
$1.71B
$618K ﹤0.01%
39,922
+661
+2% +$10.2K
RXRX icon
1098
Recursion Pharmaceuticals
RXRX
$1.73B
$615K ﹤0.01%
125,994
+2,934
+2% +$15.4K
TSLX icon
1099
Sixth Street Specialty
TSLX
$1.81B
$614K ﹤0.01%
26,857
-114
-0.4% -$2.74K
CET
1100
Central Securities Corp
CET
$1.65B
$612K ﹤0.01%
11,917
-5,375
-31% -$266K

Similar funds

Guggenheim Capital's Q3 2025 Portfolio in Review

As of Q3 2025, Guggenheim Capital held 1,675 positions worth $13.8B, up 9.4% from $12.6B the previous quarter. Its ten largest holdings account for 24% of the portfolio.

Guggenheim Capital's Q3 2025 filing shows 92 new, 753 increased, 716 reduced and 103 closed positions. Its largest new stake was Thomson Reuters: 100,588 shares worth $15.9M. The largest sale was NVIDIA, an estimated $16.8M.

By sector, the portfolio is most concentrated in Technology at 30% of assets, up from 29% a quarter earlier, followed by Consumer Discretionary and Communication Services.

  • Guggenheim Capital's largest Q3 2025 buy was Thomson Reuters: 100,588 shares worth $15.9M.
  • Guggenheim Capital added most to State Street SPDR S&P 500 ETF Trust in Q3 2025, an estimated $48.1M increase.
  • Guggenheim Capital's biggest Q3 2025 reduction was NVIDIA, cutting an estimated $16.8M.
  • Guggenheim Capital fully exited Ansys in Q3 2025, selling an estimated $8.94M.
  • Guggenheim Capital's ten largest holdings make up 24% of its $13.8B portfolio in Q3 2025.
  • Guggenheim Capital opened 92 new positions and closed 103 in Q3 2025.
  • Guggenheim Capital's portfolio value rose 9.4% quarter-over-quarter to $13.8B.

Based on Guggenheim Capital's 13F filing for Q3 2025, filed 13 Nov 2025.